Cardinal Health Inc. stock (US14149Y1082): steady gains and income profile in focus after recent dividend data
05.06.2026 - 19:04:41 | ad-hoc-news.de
Cardinal Health Inc. is back on the radar of U.S. equity investors as the New York Stock Exchange-listed healthcare stock trades close to its recent highs while offering a modest yield for income-focused portfolios, with fresh information on its annual dividend and ex-dividend timetable drawing attention.
The stock traded around the low-200 USD range in early June 2026, giving the company a market capitalization of about USD 47 billion and implying a price-to-earnings ratio near 31, according to recent quote data for CAH on major U.S. trading platforms as of 06/03/2026.
This places Cardinal Health firmly among the larger healthcare services names on the NYSE, and its share performance over recent months has seen it rank among stocks with notable percentage gains on U.S. exchanges on a monthly basis as highlighted by June 2026 performance overviews for U.S.-listed equities.
For investors looking at Cardinal Health from a U.S. home-country perspective, the primary reference point remains its NYSE listing under the ticker CAH and its trading in U.S. dollars, while its inclusion in lists of U.S. healthcare gainers underscores the domestic focus of market interest in the shares.
Dividend data have also been updated in the market, with Cardinal Health currently carrying an indicated annual dividend of USD 2.04 per share and a forward yield of roughly 1.0 percent based on early June 2026 price levels, according to dividend-tracking services as of 06/02/2026.
The payout is structured on a quarterly schedule, and the next ex-dividend date has been flagged for 07/01/2026, meaning shareholders must typically own the stock before that date to qualify for the upcoming distribution in the next payment cycle.
On most recent available closing data, Cardinal Health shares were reported near USD 201.74 in the opening days of June 2026, with that level corresponding to a market capitalization of approximately USD 47.25 billion and securing the company a place among the better-performing healthcare names in U.S. monthly gainers rankings.
While daily price fluctuations continue to reflect broader sector sentiment and macroeconomic factors, the recent combination of capital appreciation and a defined dividend profile has kept Cardinal Health on watch lists for investors who monitor both price performance and cash returns.
As of: 06/05/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: Cardinal Health
- Sector/industry: Healthcare distribution and services
- Headquarters/country: Dublin, United States
- Core markets: United States and selected international healthcare markets
- Key revenue drivers: Pharmaceutical distribution, medical products, and related healthcare services
- Home exchange/listing venue: New York Stock Exchange (CAH)
- Trading currency: USD
Cardinal Health Inc.: core business model
Cardinal Health Inc. operates as a large-scale healthcare distributor that channels pharmaceuticals and medical products from manufacturers to hospitals, pharmacies, and other care providers, with revenue primarily generated through high-volume distribution and complementary services in the U.S. healthcare system.
Valuation metrics and multiples for Cardinal Health Inc.
Valuation remains a key topic for Cardinal Health Inc. on this Friday focus, with investors watching how the market prices the company relative to its earnings and cash returns in the broader context of U.S. healthcare distributors.
Based on recent indications from early June 2026, Cardinal Health traded at roughly USD 201 to USD 205 per share, translating into a market capitalization in the area of USD 47 billion and an earnings multiple close to 30 on a trailing basis, according to composite quote and valuation data for CAH as of 06/03/2026.
That price-to-earnings ratio positions Cardinal Health at a modest premium versus some diversified value-oriented sectors, while placing it roughly in line with portions of the U.S. healthcare services peer group where stable cash flows and defensiveness often support mid- to high-20s earnings multiples in certain market phases.
On the income side, Cardinal Health carries an annualized dividend of USD 2.04 per share as of 06/02/2026, which translates to a yield of about 1.0 percent when measured against an early June 2026 share price near USD 200, underscoring that the stock is primarily viewed as a total-return holding rather than a high-yield income play.
Dividend information also points to a quarterly payout cadence, with the next ex-dividend date scheduled for 07/01/2026, giving investors a clear timeline for when new buyers would need to own the stock to participate in the upcoming dividend cycle.
While a yield around 1 percent is modest compared with higher-yielding sectors such as utilities or telecoms, the regular cash distributions can still play a role in total return calculations, particularly for long-term holders who focus on both share price evolution and recurring income from established healthcare companies.
Valuation discussions around Cardinal Health also take into account the broader market environment in U.S. equities, where healthcare services stocks have recently participated in sector recoveries tied to managed care and related names, and where defensive growth attributes can become more attractive when investors reassess cyclical risk.
For Cardinal Health specifically, the combination of a mid- to high-20s earnings multiple and a low, but consistent, dividend yield means that investor attention often centers on the companys ability to sustain earnings growth and cash generation in its distribution and medical segments over the medium term.
Any change in earnings expectations, whether through quarterly reports or updated guidance, can therefore have an outsized effect on how comfortably the current valuation levels are perceived in relation to both peer companies and the broader healthcare universe.
In summary, the latest data suggest that Cardinal Healths valuation is anchored by a mix of stable healthcare demand, moderate income distribution, and market expectations for ongoing earnings delivery that justify its current price-to-earnings profile.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on Cardinal Health Inc.
Market participants are discussing Cardinal Health Inc. in the context of recent share price levels, dividend information, and valuation metrics, with investors weighing how the stocks total-return profile compares to other U.S. healthcare service names.
Conclusion
Cardinal Health Inc. remains firmly rooted in the U.S. healthcare landscape, with its NYSE listing, sizable market capitalization, and early June 2026 share price levels underlining its role as a large-cap distributor of pharmaceuticals and medical products.
The latest data on its dividend, including an annual payout of USD 2.04 per share, a yield of about 1 percent, and a forthcoming ex-dividend date of 07/01/2026, provide clarity for investors who incorporate income considerations into their assessment of the stock.
Set against a price-to-earnings multiple near 30 and the valuations of other healthcare service companies, Cardinal Healths investment case continues to depend on the markets view of its ability to sustain earnings and cash generation, which will remain central themes as future quarterly updates and sector developments unfold.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
